Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ANNX Annexon Inc
- Stocks
- Healthcare
- NASDAQ: ANNX
Price (delayed)
$2.01
Market cap
$220.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.18
Enterprise value
$150.68M
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on
Highlights
Annexon's debt has decreased by 8% YoY and by 2.3% from the previous quarter
Annexon's EPS has increased by 19% YoY but it has decreased by 17% QoQ
Annexon's quick ratio has plunged by 61% YoY and by 23% from the previous quarter
The company's net income fell by 39% YoY and by 21% QoQ
Key stats
What are the main financial stats of ANNX
Market
Valuations
Earnings
Shares outstanding
109.71M
Market cap
$220.53M
Enterprise value
$150.68M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.9
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$182.91M
Net income
-$167.38M
EBIT
-$167.38M
EBITDA
-$163.88M
Free cash flow
-$139.88M
Per share
Balance sheet
Liquidity
EPS
-$1.18
EPS diluted
-$1.18
Free cash flow per share
-$0.94
Book value per share
$2.22
Revenue per share
$0
TBVPS
$2.05
Total assets
$303.03M
Total liabilities
$59.24M
Debt
$28.31M
Equity
$243.79M
Working capital
$234.62M
Debt to equity
0.12
Current ratio
7.99
Quick ratio
7.89
Net debt/EBITDA
0.43
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-46.6%
Return on equity
-54.5%
Return on invested capital
-62.8%
Return on capital employed
-62.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANNX stock price
How has the Annexon stock price performed over time
Intraday
11.05%
1 week
25.63%
1 month
40.56%
1 year
-53.9%
YTD
-60.82%
QTD
4.15%
Financial performance
How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$182.91M
Net income
-$167.38M
Gross margin
N/A
Net margin
N/A
The company's operating income fell by 40% YoY and by 19% QoQ
The company's net income fell by 39% YoY and by 21% QoQ
Price vs fundamentals
How does ANNX's price correlate with its fundamentals
Growth
What is Annexon's growth rate over time
Valuation
What is Annexon stock price valuation
P/E
N/A
P/B
0.9
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 19% YoY but it has decreased by 17% QoQ
The P/B is 47% lower than the 5-year quarterly average of 1.7 and 40% lower than the last 4 quarters average of 1.5
The equity has declined by 17% since the previous quarter and by 7% year-on-year
Efficiency
How efficient is Annexon business performance
The return on invested capital has grown by 39% year-on-year but it has declined by 18% since the previous quarter
The ROE has declined by 23% since the previous quarter but it is up by 3.5% year-on-year
ANNX's ROA is down by 21% QoQ
Dividends
What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANNX.
Financial health
How did Annexon financials performed over time
Annexon's current ratio has plunged by 61% YoY and by 23% from the previous quarter
Annexon's quick ratio has plunged by 61% YoY and by 23% from the previous quarter
Annexon's debt is 88% less than its equity
The debt to equity has grown by 20% since the previous quarter
The equity has declined by 17% since the previous quarter and by 7% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.